Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Atara Biotherapeutics, Inc. (ATRA)
Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
08/16/2023 | Murugan Amar | EVP, Chief Legal Officer | Sale | Common Stock | 5k | $1.65 | $8.3k | | 08/16/2023 |
08/16/2023 | Murugan Amar | EVP, Chief Legal Officer | Sale | Common Stock | 3.6k | $1.65 | $6k | | 08/16/2023 |
08/16/2023 | Touchon Pascal | President and CEO | Sale | Common Stock | 21.4k | $1.65 | $35.4k | | 08/16/2023 |
08/16/2023 | Touchon Pascal | President and CEO | Sale | Common Stock | 9.3k | $1.65 | $15.4k | | 08/16/2023 |
08/16/2023 | Henrich Jill | EVP, Global Head RA & Quality | Sale | Common Stock | 2.8k | $1.65 | $4.6k | | 08/16/2023 |
08/16/2023 | Henrich Jill | EVP, Global Head RA & Quality | Sale | Common Stock | 558 | $1.65 | $922.9 | | 08/16/2023 |
08/16/2023 | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sale | Common Stock | 5.8k | $1.65 | $9.7k | | 08/16/2023 |
08/16/2023 | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sale | Common Stock | 9.3k | $1.65 | $15.3k | | 08/16/2023 |
08/16/2023 | Joshi Manher | EVP, Chief Medical Officer | Sale | Common Stock | 3.2k | $1.65 | $5.3k | | 08/16/2023 |
08/16/2023 | Joshi Manher | EVP, Chief Medical Officer | Sale | Common Stock | 3.8k | $1.65 | $6.2k | | 08/16/2023 |
08/16/2023 | Hyllengren Eric J | SVP, CFO | Sale | Common Stock | 6.4k | $1.65 | $10.6k | | 08/16/2023 |
08/16/2023 | Hyllengren Eric J | SVP, CFO | Sale | Common Stock | 1.8k | $1.65 | $2.9k | | 08/16/2023 |
06/27/2023 | Touchon Pascal | President and CEO | Sale | Common Stock | 14.3k | $1.66 | $23.7k | | 06/27/2023 |
05/31/2023 | SEIDENBERG BETH C | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | SEIDENBERG BETH C | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | MALLIK AMEET | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | MALLIK AMEET | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | DOBMEIER ERIC | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | DOBMEIER ERIC | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | HEIDEN WILLIAM K | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | HEIDEN WILLIAM K | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | Roncarolo Maria Grazia | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | Roncarolo Maria Grazia | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | Gallagher Carol Giltner | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | Gallagher Carol Giltner | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/31/2023 | Fust Matthew K | Director | Grant | Common Stock | 57k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | Fust Matthew K | Director | Grant | Non-Qualified Stock Option (Right to Buy) | 79.5k | $1.53 | $121.6k | | 05/31/2023 |
05/16/2023 | Murugan Amar | EVP, Chief Legal Officer | Sale | Common Stock | 7.4k | $2.04 | $15.1k | | 05/16/2023 |
05/16/2023 | Murugan Amar | EVP, Chief Legal Officer | Sale | Common Stock | 985 | $2.04 | $2k | | 05/16/2023 |
05/16/2023 | Banard Charlene A. | EVP, Chief Technical Officer | Sale | Common Stock | 19k | $2.04 | $38.8k | | 05/16/2023 |
05/16/2023 | Hyllengren Eric J | SVP, CFO | Sale | Common Stock | 6.2k | $2.04 | $12.6k | | 05/16/2023 |
05/16/2023 | Hyllengren Eric J | SVP, CFO | Sale | Common Stock | 1.7k | $2.04 | $3.5k | | 05/16/2023 |
05/16/2023 | Touchon Pascal | President and CEO | Sale | Common Stock | 29.8k | $2.04 | $60.6k | | 05/16/2023 |
03/02/2023 | Koppikar Utpal | CFO | Sale | Common Stock | 6.9k | $3.63 | $24.9k | | 03/02/2023 |
03/02/2023 | Dupont Jakob | EVP, Head of R&D | Sale | Common Stock | 5.1k | $3.63 | $18.4k | | 03/02/2023 |
|
|